Virus could set back tuberculosis fight by several years

Image
AP Johannesburg
Last Updated : May 06 2020 | 6:36 PM IST

The fight against tuberculosis could be set back by more than five years due to the coronavirus pandemic, risking an additional 1.4 million TB deaths and 6.3 million infections by 2025, a new report says.

The Stop TB Partnership is a Geneva-based international body leading the global fight against the respiratory illness that infects more than 10 million people annually.

Data from three countries with high TB prevalence, Kenya, India and Ukraine, was used for the new report. Kenya is among the countries with the highest TB burden in the world with an estimated 558 people in every 100,000 infected.

The study says coronavirus lockdowns affecting poor people who cannot practice social distancing in their homes mean higher risk of TB transmission while restricted movements disrupt treatment. The repurposing of TB hospitals and services for coronavirus testing and treatment also is taking a toll.

In extreme cases where lockdowns last up to three months, the study estimates that it might take up to 10 months for restore TB services to normal levels.

Addressing the disease will take far longer.

In fact, it takes several years for the elevated TB burden to come back to pre-lockdown levels. The more severe the lockdown, the more severe the long-term impact, Nimalan Arinaminpathy, an associate professor in mathematical epidemiology at Imperial College London, told reporters.

Other unintended effects of the COVID-19 outbreak include the stigma that TB patients might face, said Cheri Vincent, chief of the TB division at USAID.

Here you have people who have similar symptoms to those of the coronavirus, and some would be even afraid of approaching health facilities because they would face the stigma of being identified as having COVID-19," she said.

She also expressed concern that COVID-19 could have a devastating effect on TB patients as both diseases attack the respiratory system.

Researchers behind the study also lamented the sudden capacity given to research and development for a COVID-19 vaccine compared to that for TB over the years.

We are looking with amazement at how COVID-19 has been around some 128 days but already has about 100 candidate vaccines," said Stop TB executive director Lucica Ditiu. The new agenda is vaccines and treatment for COVID-19. Nobody is talking about vaccines for HIV, malaria or TB.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 06 2020 | 6:36 PM IST

Next Story